GlassScriptPhysician profile
Barbara Ingrid Held
NPI 1861401457
$1,594.20
in general payments reported to CMS, 2019-2025
25 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $229 · 2020: $89.64 · 2021: $389 · 2022: $537 · 2023: $291 · 2024: $58.25.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $350.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $349.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $238.74 | 2019-2022 | |
| Pfizer INC. | $215.49 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $135.61 | 2021-2023 | |
| Astellas Pharma US INC | $129.48 | 2022-2023 | Veozah |
| Therapeuticsmd, INC. | $103.31 | 2021-2022 | |
| Axonics, INC. | $88.96 | 2023 | Axonics |
| Daiichi Sankyo INC. | $79.85 | 2022-2024 | Injectafer |
| Avion Pharmaceuticals | $79.56 | 2019-2021 | |
| Pacira Pharmaceuticals Incorporated | $75.36 | 2021-2023 | Iovera, Exparel |
| Hologic Sales and Service, LLC | $73.91 | 2019-2023 | Affirm Prone Biopsy System |
| Myovant Sciences INC. | $55.67 | 2021 | |
| Mayne Pharma Commercial LLC | $37.67 | 2021-2022 | |
| Evofem Biosciences, INC. | $34.39 | 2021 | |
| Medtronic, INC. | $33.41 | 2022-2024 | Truclear |
| Sumitomo Pharma America, INC. | $28.13 | 2023 | Myfembree |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $26.93 | 2019-2021 | |
| Coopersurgical, INC. | $24.60 | 2019-2021 | |
| Aspira Women'S Health INC | $23.43 | 2022 | |
| Alexion Pharmaceuticals, INC. | $22.99 | 2022 | |
| Abbott Laboratories | $21.82 | 2022 | |
| Biotissue Holdings INC. | $14.99 | 2024 | |
| Organon LLC | $13.39 | 2021 | |
| Amag Pharmaceuticals, INC. | $12.51 | 2019 | |
| Convatec INC. | $12.30 | 2022 | |
| Ascend Therapeutics US, LLC | $11.70 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Barbara Held listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.